Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis
A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma
† Study has passed its completion date and status has not been verified in more than two years.